DIMERIX LIMITED

Press Releases Dimerix Limited

Equities

DXB

AU000000DXB7

Market Closed - Australian S.E. Other stock markets 02:10:09 2024-07-09 am EDT			5-day change	1st Jan Change
0.44 ^AUD	0.00%		-16.19%	+114.63%

Jul. 04	Dimerix to Recruit Adolescents for Kidney Drug Study; Shares Decline 7%	MT
May. 29	Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ADVANZ PHARMA and Dimerix enter into an Exclusive License Agreement to commercialise DMX-200 in Europe, Canada, Australia, and New Zealand	23-10-05	AQ
Dimerix : Quarterly Appendix 4C and Activities Report	22-07-26	PU
Dimerix : to Present at BIO International Convention	22-06-05	PU
Dimerix : Quarterly Appendix 4C and Activities Report	22-04-26	PU
Dimerix : Investor Call and Presentation	22-02-28	PU
Dimerix : Half-Year Financial Report & Appendix 4D - 31 December 2021	22-02-23	PU
Dimerix : Notification regarding unquoted securities - DXB	21-12-05	PU
DIMERIX : DMX-200 Posts Strong Results in Kidney Disease Trial	20-07-29	BU
Dimerix : Holds Pre-IND Meeting on DMX-200 With FDA	19-11-24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer